[Terfenadine compared to clemastine in the treatment of pruriginous cutaneous diseases. Double-blind comparative study].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D002974:Clemastine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011759:Pyrrolidines / Q000627:therapeutic use*; D011897:Random Allocation; D016593:Terfenadine
D001559:Benzhydryl Compounds; D006634:Histamine H1 Antagonists; D011759:Pyrrolidines; D016593:Terfenadine; D002974:Clemastine
Terfenadina frente a clemastina en el tratamiento de las enfermedades cutáneas pruriginosas. Estudio comparativo doble-ciego.